CD86 regulates myeloma cell survival

Although prognosis for patients with multiple myeloma has improved over the past decade, research toward discovery of new therapeutic avenues is important and could lead to a cure for this plasma cell malignancy. Here we show that blocking the CD28-CD86 pathway via silencing of either CD28 or CD86 l...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Gavile, Catherine M., Barwick, Benjamin G., Newman, Scott, Neri, Paola, Nooka, Ajay K., Lonial, Sagar, Lee, Kelvin P., Boise, Lawrence H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2017
Soggetti:
Lymphoid Neoplasia
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729629/
https://ncbi.nlm.nih.gov/pubmed/29296880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011601
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi